You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Melanoma Surveillance Photography

Showing 1 - 25 of 5,489
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Melanoma, Skin Cancer, Anxiety and Fear Trial in Australia (2D or 3D Melanoma Surveillance Photography)

Recruiting
  • Melanoma
  • +2 more
  • 2D or 3D Melanoma Surveillance Photography
  • Camperdown, New South Wales, Australia
  • +11 more
Aug 22, 2022

Non-melanoma Skin Cancer Trial in Dresden (optical coherence tomography, in vivo reflectance confocal microscopy, 3D total body

Completed
  • Non-melanoma Skin Cancer
  • optical coherence tomography, in vivo reflectance confocal microscopy, 3D total body photography
  • Dresden, Saxony, Germany
    Klinik und Poliklinik für Dermatologie, Carl Gustav Carus Dresde
Apr 24, 2023

Phase of Uveal Melanoma: A Prospective Multi-method Study

Not yet recruiting
  • Uveal Melanoma
  • Questionnaires and interviews
  • (no location specified)
Oct 4, 2023

Melanoma (Skin), Moles Multiple Benign Trial in Headington (Total body photography)

Recruiting
  • Melanoma (Skin)
  • Moles Multiple Benign
  • Total body photography
  • Headington, Oxford, United Kingdom
    Churchill Hospital
Sep 21, 2021

Melanoma Detection in Switzerland With VECTRA

Recruiting
  • Melanoma (Skin)
  • 3D imaging Total Body Photography Vectra® WB360
  • +3 more
  • Basel, Switzerland
    Department of Dermatology, University Hospital Basel
Apr 11, 2022

Cutaneous Melanoma Trial in Copenhagen (The MelaCare intervention)

Recruiting
  • Cutaneous Melanoma
  • The MelaCare intervention
  • Copenhagen, Denmark
    Herlev and Gentofte Hospital
Mar 11, 2022

Yervoy® Postmarketing Surveillance for Japan With Unresectable,

Completed
  • Melanoma
    • Chiyoda-ku, Tokyo, Japan
    • +1 more
    Feb 11, 2022

    Yervoy Pregnancy Surveillance Study

    Withdrawn
    • Melanoma
    • Baltimore, Maryland
      UBC
    Mar 16, 2022

    Melanoma (Skin) Trial in Newcastle, North Sydney, Sydney (Self-examination of the skin)

    Completed
    • Melanoma (Skin)
    • Self-examination of the skin
    • Newcastle, New South Wales, Australia
    • +2 more
    Mar 11, 2021

    iToBoS Prospective Data Acquisition Study (Barcelona)

    Recruiting
    • Skin Cancer
      • Barcelona, Catalonia, Spain
        Hospital Clinic de Barcelona
      Jul 18, 2023

      Melanoma Trial in Jette, Brussels (follow up DW MRI)

      Recruiting
      • Melanoma
      • follow up DW MRI
      • Jette, Brabant, Belgium
      • +1 more
      Dec 16, 2020

      Dysplastic Nevus, Health Status Unknown, Melanoma Trial in New Brunswick (Best Practice, mySmartCheck, Survey Administration)

      Completed
      • Dysplastic Nevus
      • +3 more
      • Best Practice
      • +2 more
      • New Brunswick, New Jersey
        Rutgers Cancer Institute of New Jersey
      Apr 5, 2022

      Melanoma, NSCLC Trial (Evaluation of ctDNA using the F1T after 1 year of immunotherapy)

      Not yet recruiting
      • Melanoma
      • Non-small Cell Lung Cancer
      • Evaluation of ctDNA using the F1T after 1 year of immunotherapy
      • (no location specified)
      Nov 24, 2023

      Generation ofArtificial Intelligence Algorithm Based on Analysis

      Not yet recruiting
      • Metastatic Melanoma
      • Photo
      • (no location specified)
      May 3, 2023

      Uveal Melanoma Trial in Worldwide

      Recruiting
      • Uveal Melanoma
        • Boston, Massachusetts
        • +14 more
        Jun 28, 2022

        PD-1 Refractory Advanced Melanoma Trial in Pittsburgh (Responder-Derived Fecal microbiota transplantation (R-FMT, Pembrolizumab,

        Not yet recruiting
        • PD-1 Refractory Advanced Melanoma
        • Responder-Derived Fecal microbiota transplantation (R-FMT
        • +2 more
        • Pittsburgh, Pennsylvania
          UPMC Hillman Cancer Center
        Sep 1, 2023

        Metastatic Melanoma, Skin Cancer Trial in Boston (Ipilimumab, Nivolumab, Cryoablation)

        Not yet recruiting
        • Metastatic Melanoma
        • Skin Cancer
        • Boston, Massachusetts
          Massachusetts General Hospital Cancer Center
        Mar 9, 2023

        Melanoma Trial in Houston (Immunotherapy, Quality-of-Life Assessment, Radiation Therapy)

        Recruiting
        • Melanoma
        • Immunotherapy
        • +2 more
        • Camden, New Jersey
        • +1 more
        Nov 11, 2022

        Skin Cancer, Melanoma (Skin) Trial in Melbourne (Molemap Skin Cancer Triage Artificial Intelligence Device)

        Completed
        • Skin Cancer
        • Melanoma (Skin)
        • Molemap Skin Cancer Triage Artificial Intelligence Device
        • Melbourne, Victoria, Australia
        • +1 more
        Aug 12, 2021

        Melanoma Recurrence With Circulating Tumor DNA (ctDNA)

        Active, not recruiting
        • Melanoma
          • Murray, Utah
          • +1 more
          Feb 17, 2023

          Nevi and Melanomas Trial in Aurora (UV Counseling, UV Photo, Biological Sample)

          Recruiting
          • Nevi and Melanomas
          • UV Counseling
          • +2 more
          • Aurora, Colorado
            University of Colorado
          Apr 4, 2022

          Melanoma, Acral Melanoma, Temozolomide Trial (Camrelizumab)

          Not yet recruiting
          • Melanoma
          • +6 more
          • (no location specified)
          Aug 21, 2022

          Melanoma, Merkel Cell Carcinoma, Other Solid Tumors Trial in Middletown, Harrison, New York (TALIMOGENE LAHERPAREPVEC (TVEC),

          Active, not recruiting
          • Melanoma
          • +2 more
          • TALIMOGENE LAHERPAREPVEC (TVEC)
          • Hypofractionated Radiotherapy
          • Middletown, New Jersey
          • +2 more
          Jul 13, 2022

          Data of Intravitreal Aflibercept Injection in Patients of Wet

          Completed
          • Wet Age-related Macular Degeneration
          • Aflibercept (Eylea, BAY86-5321)
          • Multiple Locations, India
            Many Locations
          Feb 2, 2023

          Melanoma Stage III Trial in North Sydney (Pembrolizumab, Lenvatinib)

          Recruiting
          • Melanoma Stage III
          • North Sydney, New South Wales, Australia
            Melanoma Institute Australia
          Oct 26, 2022